Simultaneous arterial dilution curves in normal man of I 131 -human serum albumin (HSA) and Cr
51
-labeled red cells (Cr-51 RBC) performed in this laboratory 3 ( fig. 1 ) demonstrated that: (1) a discrepancy between the apparent direct (I 13I -HSA) and indirect (CR 51 -RBC) plasma volumes became evident with the first appearance of systemic recirculation; and (2) the apparent body/large vessel hematocrit ratio (B/LVH ratio) remained approximately the same during the next several minutes. These data were interpreted to indicate that a significant amount of I 131 -HSA did not escape the intravascular space during the first several minutes post injection, and that the "extra" direct plasma was rapidly equilibrating with respect to albumin. Supported by research grants from the American Heart Association; the National Heart Institute (H-2509), U. S. Public Health Service; Ciba Pharmaceuticals, Inc., Summit, New Jersey; and Charles Pfizer & Company, Inc., Brooklyn, New York.
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Methods
The patients were divided into two groups. Group 1 consisted of eight patients with severe edema due to congestive heart failure (table 1). Group 2 consisted of six patients with moderate to severe edema associated with chronic glomerulonephritis (B.J. and I.F.), disseminated lupus erythematosis (P.F.), pre-eelampsia (M.B.), Kimmelstiel-AVilson syndrome (J.AV.), and careinomatosis (R.R.) (table 2). Only one patient (J.W.) had clinical signs of pulmonary edema. The diagnoses of the patients in group 2 were all confirmed by biopsy or postmortem study except for the patient with pre-eclampsia.
The subjects were studied in the fasting state, having been confined to bed for at least 24 hours prior to study. Each patient's legs were horizontal, but the upper portions of the body were elevated 30 to 45 degrees to avoid respiratory difficulties. Indicators were injected during a three-second interval into an anteeubital vein through a 20-gauge needle from a calibrated syringe. Samples were collected in tubes containing dried heparin from the femoral artery in 12 procedures and from an anteeubital vein (opposite to that of injection) in 2 procedures. The radioactivity of the samples was determined in a scintillation well counter." Samples and background were counted for periods which gave an accuracy of ± 1 per cent in the sample count rate corrected for background.
The dosages of the indicators administered were approximately 30 /ic. I 131 T-HSA and 100 /xc. Cr 51 .J Prior to administration, a suspension of the patients' red cells was incubated with the radioactive chromate and washed three times with normal saline. 4 Just prior to injection, I 131 -HSA was added with 1 ml. of the patient's plasma to prevent absorption of I 131 -HSA to the walls of the equipment used during administration and later during preparation of standards. 5 Hematocrit determinations (including those of the injected solution) were measured in Wintrobe tubes, spun in an International centrifuge having a radius of ±9 cm. from the center of spindle to tip of column of blood, at approximately 2,000 r.p.m. for 30 minutes. A standard correction of 5 per cent for trapped plasma was used, 6 the variations in this correction due to different hematocrits being considered too small for consideration. 7 All patients' hematocrits were performed on arterial samples, except in those two procedures in which the dilution curves were from venous samples.
Femoral arterial samples were collected at threesecond intervals following the beginning of the injection of the isotopes in three patients (L M., M.S., J.W.) and approximately as follows in all patients from whom arterial samples were collected : every three seconds between 40 and 60 seconds post injection; then at 15-or 20-second intervals until four minutes post injection; then every minute until 10 minutes post injection; then at 13, 16, and 20 minutes post injection; and, finally, every 5 or 10 minutes until approximately 60 (100 in one procedure) minutes post injection. The venous samples (L.W., I.F.) were collected: one to three times per minute during the first four minutes post injection; then at similar time intervals as above.
Apparent plasma and red cell volumes (tables 1 and 2) are defined here as those volumes for a particular time based on the radioactivity in a sample obtained at that time. Therefore: the apparent direct plasma volume at time t = counts injected (I 131 -HSA) counts/ml, of plasma at time t the apparent indirect plasma volume at time t = counts injected (Cr 51 -RBC) X 1 hematocrit counts/ml, whole blood at time t ' the apparent red cell volume at time t = counts injected Cr 51 -RBC . counts/ml, of packed red cells at time t The apparent body to large vessel hematocrits ratio (B/LVHR) is here defined at this ratio for a particular time, i.e., apparent red cell volume (time t) apparent red cell volume (time t) + apparent direct plasma volume (time t) arterial or antecubital vein hematocrit Direct and indirect plasma volumes were also obtained by extrapolation of the later disappearance slopes to the time of injection and are indicated in tables 1 and 2. The extrapolated body/large vessel hematocrit ratio was also calculated using these values and are presented in tables 1 and 2.
Results
In normal man, the arterial dilution curves of both isotopes are similar and can be divided into five parts: 3 (1) initial periodic portion, (2) phase 1, (3) phase 2, (4) final mixing period, and (5) here are analyzed in similar fashion and compared with those curves from normal patients. Initial Periodic Portion and Phase 1
Arterial samples were collected during the first 40 seconds post injection in only 3 (L.M., M.S., J.M.) of the 14 eases. The delay in the beginning of sampling and the slow circulation time in these patients made it difficult to distinguish between the down slope of the initial periodic portion and phase 1.
Phase 2
The next portion of both dilution curves began during the second minute post injection. This phase represented a rapid dilution of the indicators (tables 1 and 2), and disappearance slopes could be approximated. The average times of completion post injection and percentage disappearance per hour (calculated by extrapolating this portion of the curve over a 60-minute period) were in group 1: I I31 -HSA 7.4 ± 3.1 minutes (77 ± 17 per cent), Cr si -RBC 4.9 ± 3.2 minutes (86 ± 21 per cent), and in group 2: I 131 -HSA 9.8 ± 1.1 minutes (63 ± 10 per cent), Cr 51 -RBC 3.6 ± 0.6 minute (80 ± 18 per cent).
Final Mixing Period
After the rapidly diluting portions of the indicator curves in both groups 1 and 2, there occurred in some patients (though less frequently than in the normal subjects) a period when there were fluctuations of concentration in radioactivity during which it was difficult to construct a reliable disappearance slope. Since many of the patients did not demonstrate this period, the averages presented below were calculated from the end of the final mixing period or the end of phase 2 when the former period was not present. Case J.B. was not included in these averages. The final part of the curve in both groups 1 and 2 was a gentle I 131 -HSA disappearance slope (fig. 4) (pre-eclampsia) were above the upper limit presented in most series for normals 1 ' 2 and for patients with congestive heart failure. 8 -°T hat those data are due to individual patient variation 10 ' n and not laboratory error is suggested by studies redone in patients E.D. and M.B. several weeks later when they were clinically nonedematous. In the repeat studies, the extrapolated B/LVH ratios were 0.98 and 1.02, respective]}'.
Discussion
Since any discussion of the dilution curves in edematous patients presented here must necessarily center around their similarity to or difference from the curves of normal patients, a review of the data from normal subjects seems in order. In normal man, the oneor two-hour dilution curves of I 131 -HSA and Cr 51 -RBC are similar and can be divided into five parts. 3 Of particular interest are the observations that: (1) I 131 -HSA and Cr
51
-RBC complete the period of rapid mixing (end of phase 2) in the same period of time; (2) a significant difference between the apparent direct and indirect plasma volumes appears with the first evidence of systemic reeireulation; and (3) the apparent B/LVH ratio remains approximately the same during the entire period of rapid mixing (phases 1 and 2). The latter two observations are in agreement with those obtained by Bauraan et al. Previously, 3 we hypothesized that this rapidly equilibrating "extra" direct albumin space is largely intravascular, since, even if an excessively protein-permeable capillary network does exist, the relative slowness of filtration and the slow diffusion of the large albumin molecule 14 would not allow I 131 -HSA equilibration between extra-and intravascular spaces in the required short period of one capillary transit time. Necessarily, also, the Circulation Research, Volume IX, September 1061 data are inconsistent with the hypothesis of Smith, Arnold, and Whipple 13 ' 16 that the "extra" direct plasma is located in a stagnant, slowly equilibrating marginal layer of small vessel plasma. This latter conclusion is also supported by recent work of Sliwinski and Lillienfield 17 who, using simultaneous administration of labeled red cells and macroglobulin, demonstrated a significant amount of rapidly equilibrating "extra" direct plasma in the hind limb of the dog. Indeed, the slow diffusion of I 131 -HSA would seem even to argue against significant red-cell streaming (i.e., with a peripheral layer of rapidly equilibrating plasma) in the large majority of small vessels. While it is true that direct observation has shown some small vessels to have axial red-cell streaming, 18 and the experiments of Fahraeus in relatively large straight glass tubes (50 to 300 /x diameter) demonstrate this axial streaming, 1 " many other small vessels 18 -'-"• 21 demonstrate now in which only plasnia is present or in which groups of red cells are separated by relatively large areas of plasma. It would seem then that any speculation as to the cause of the discrepancy between direct and indirect plasma volume measurements should certainly consider these latter two observations. The dilution curves in patients with edema associated with congestive heart failure (group 1), when compared to those of normal subjects, show a tendency for prolongation of the periods of rapid (phase 2) and final mixing of both indicators. Slow plasma protein and red-cell mixing to such patients has been reported before by others.' 2 -23 Further analysis of the dilution curves indicate that, in six of the eight patients with congestive heart failure, there is no significant loss of I 13I -ILSA from the intravascular compartment during the first several minutes post injection. In these six patients, the time for completion of rapid mixing (end of phase 2) was similar for both isotopes. In four of the six patients (J.P., E.D., W.N., L.M.), the B/LVH ratio during the first minute post injection was approximately the same as this ratio at the end of rapid mixing. In the two TUCKMAX, FINNBRTY remaining of these six patients (L.W., M.S.), whereas a large difference existed between the ratio at one minute post injection and that at the end of rapid mixing, there was no significant difference between the two-minute ratio and that at the end of rapid mixing. It is probable that the difference between the first-and second-minute ratios in these two patients was due to slow whole blood intravascular mixing, so that the first-minute B/LVH ratio was less influenced by the lower hematocrit of the small vessels. In patient L.W., the dilution curves were based on venous samples; in patient M.S., mixing was so slow at one minute that I 131 -HSA and Cr 51 -RBG were only 25 and 35 per cent mixed (the extrapolated value at time of injection is used as 100 per cent mixing).
On the other hand, in two of the eight patients (J.B., B.L.) with congestive heart failure, there is evidence that the "extra" direct plasma was distributed in both rapidly and slowly equilibrating spaces. In both subjects, the apparent B/LVH ratio at one minute post injection was less than unity, thereby indicating a rapidly equilibrating protein intravascular space. In addition, in both patients the B/LVH ratio during the entire two minutes post injection was appreciably greater than that at the end of the period of rapid mixing (phase 2). This latter difference was not due to slow whole-blood intravascular mixing since the two-minute samples of Cr 51 were well mixed. Is this slowly equilibrating "ext r a " direct albumin space intra-or extravascularf Unless the disappearance slope of phase 3 is used as an indicator of capillary permeability to protein, the question cannot be answered. In patient B.L., the disappearance slope of phase 3 is flat during 20 to 60 minutes post injection. It might thereby be argued that the capillaries are not excessively permeable to protein, and therefore, the slowly equilibrating space in question is intravascular. Since other elements, such as lymphatic return of indicator, also affect the slope of phase 3, a discussion of the location of the slowly equilibrating albumin space in patients J.B. and B.L. would seem too speculative.
It would seem then that, as hi normal patients, a significant quantity of I m -HSA does not escape the intravascular space during the first several minutes post injection in most of the patients herein studied with edema associated with congestive heart failure. These data support those of Bramkamph and others 24 ' 2r ' who were unable to demonstrate inordinate capillary permeability to protein in congestive heart failure.
In analyzing the data from the six patients with edema not associated with congestive heart failure (group 2), definite conclusions cannot be arrived at since the group was small and composed of patients with different diseases. Nevertheless, the results are of interest in that (1) the diseases represented are, except for patient R.R., intimately associated with renal damage, low. serum albumin, and anemia; and (2) several investigators have been unable to demonstrate abnormal capillary permeability to plasma proteins in edema associated with chronic glomerulonephritis and toxemia of pregnancy.
28
In group 2, the time required to complete rapid Cr 51 -RBC mixing (end phase 2) was not longer than in normal subjects. On the other hand, in five of the six patients in this group, I m -HSA took longer than normal, and conspicuously longer than Cr 51 -EBC, to complete the period of rapid mixing. It can also be noted that in these five cases the B/LVH ratios during the entire two minutes post injection were larger than at the end of rapid mixing (phase 2). This slowly equilibrating albumin space was not dependent on slow whole-blood intravaseular mixing, since the Cr 5I -RBG were well mixed at two minutes post injection. As already indicated, it is probably unwise to use the disappearance slope of phase 3 as an indication of capillary permeability, and therefore, unfortunately, one cannot localize from the data presented for group 2, whether the slowly equilibrating "extra" albumin space is intra-or extravascular.
It would seem, then, that the indicator-dilution curves of the edematous patients of group 2 differ both from those derived from normal patients and most of the edematous subjects with congestive heart failure. The data are consistent with, but do not necessarily suggest, the possibility that increased capillary permeability to protein is present in these types of edema.
Summary
Detailed indicator-dilution curves of simultaneously administered I 131 -HSA and Cr 51 -RBC in six of eight edematous patients with congestive heart failure demonstrate that, as in normal patients, a significant quantity of I 131 -HSA does not escape the intravascular space during the first several minutes post injection. It would seem, therefore, that capillary permeability to albumin was not an important manifestation in these patients. Detailed indicator-dilution curves in five of six patients with edema not associated with congestive heart failure differ from those derived from normal patients and from the edematous patients with congestive heart failure. These data do not exclude the possibility that capillary permeability to albumin might be a significant concomitant of edema associated with chronic glomerulonephritis, disseminated lupus eiythematosis, toxemia of pregnancy, carcinomatosis, and Kimmelstiel -Wilson syndrome.
